Unique pattern of neutrophil migration and function during tumor progression

References 50

1. 1.

   Fridlender ZG Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16, 183–194 (2009 ).

   Not in our library10.1016/j.ccr.2009.06.017

2. 2.

   Eruslanov EB Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 124, 5466–5480 (2014 ).

   Not in our library10.1172/jci77053

3. 3.

   Veglia F, Perego M & Gabrilovich D Myeloid-derived suppressor cells coming of age. Nat Immunol in press (2018 ).

   Not in our library10.1038/s41590-017-0022-x

4. 4.

   Coffelt SB, Wellenstein MD & de Visser KE Neutrophils in cancer: neutral no more. Nat Rev Cancer 16, 431–446 (2016 ).

   Not in our library10.1038/nrc.2016.52

5. 5.

   Zhou J, Nefedova Y, Lei A & Gabrilovich D Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. Semin Immunol (2017 ).

   Not in our library10.1016/j.smim.2017.12.004

6. 6.

   Ortiz ML Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. J Exp Med 212, 351–367 (2015 ).

   Not in our library10.1084/jem.20140835

7. 7.

   Ortiz ML, Lu L, Ramachandran I & Gabrilovich DI Myeloid-derived suppressor cells in the development of lung cancer. Cancer Immunol Res 2, 50–58 (2014 ).

   Not in our library10.1158/2326-6066.cir-13-0129

8. 8.
   Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards · 2016

   No notice
9. 9.

   Seyfried TN & Huysentruyt LC On the origin of cancer metastasis. Critical reviews in oncogenesis 18, 43–73 (2013 ).

   Not in our library10.1615/critrevoncog.v18.i1-2.40

10. 10.

    Achberger S Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease. Mol Immunol 58, 182–186 (2013 ).

    Not in our library10.1016/j.molimm.2013.11.018

11. 11.

    Weide B Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells. Clin Cancer Res 20, 1601–1609 (2014 ).

    Not in our library10.1158/1078-0432.ccr-13-2508

12. 12.

    Condamine T, Ramachandran I, Youn JI & Gabrilovich DI Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med 66, 97–110 (2015 ).

    Not in our library10.1146/annurev-med-051013-052304

13. 13.

    Coffelt SB IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522, 345–348 (2015 ).

    Not in our library10.1038/nature14282

14. 14.
    Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor · 2011

    No notice
15. 15.

    Liu Y MicroRNA-494 Is Required for the Accumulation and Functions of Tumor-Expanded Myeloid-Derived Suppressor Cells via Targeting of PTEN. The Journal of Immunology 188, 5500–5510 (2012 ).

    Not in our library10.4049/jimmunol.1103505

16. 16.

    Yang L Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13, 23–35 (2008 ).

    Not in our library10.1016/j.ccr.2007.12.004

17. 17.

    Huh SJ, Liang S, Sharma A, Dong C & Robertson GP Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 70, 6071–6082 (2010 ).

    Not in our library10.1158/0008-5472.can-09-4442

18. 18.

    Ichikawa M, Williams R, Wang L, Vogl T & Srikrishna G S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 9, 133–148 (2011 ).

    Not in our library10.1158/1541-7786.mcr-10-0394

19. 19.

    Kowanetz M Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A 107, 21248–21255 (2010 ).

    Not in our library10.1073/pnas.1015855107

20. 20.

    Kolaczkowska E & Kubes P Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13, 159–175 (2013 ).

    Not in our library10.1038/nri3399

21. 21.
    Intracellular signalling during neutrophil recruitment · 2015

    No notice
22. 22.

    Kumar V, Patel S, Tcyganov E & Gabrilovich DI The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends Immunol (2016 ).

    Not in our library10.1016/j.it.2016.01.004

23. 23.

    Brandau S Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 89, 311–317 (2011 ).

    Not in our library10.1189/jlb.0310162

24. 24.

    Kato M Transgenic mouse model for skin malignant melanoma. Oncogene 17, 1885–1888 (1998 ).

    Not in our library10.1038/sj.onc.1202077

25. 25.

    Hingorani SR Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469–483 (2005 ).

    Not in our library10.1016/j.ccr.2005.04.023

26. 26.

    Greenberg NM Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A 92, 3439–3443 (1995 ).

    Not in our library10.1073/pnas.92.8.3439

27. 27.

    Evans RA Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. JCI insight 1 (2016 ).

    Not in our library10.1172/jci.insight.88328

28. 28.

    Casbon AJ Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils. Proc Natl Acad Sci U S A 112, E566–575 (2015 ).

    Not in our library10.1073/pnas.1424927112

29. 29.

    Biswas SK Metabolic Reprogramming of Immune Cells in Cancer Progression. Immunity 43, 435–449 (2015 ).

    Not in our library10.1016/j.immuni.2015.09.001

30. 30.

    Chen Y ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314, 1792–1795 (2006 ).

    Not in our library10.1126/science.1132559

31. 31.

    Chen Y Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 3, ra45 (2010 ).

    Not in our library10.1126/scisignal.2000549

32. 32.

    Junger WG Purinergic regulation of neutrophil chemotaxis. Cell Mol Life Sci 65, 2528–2540 (2008 ).

    Not in our library10.1007/s00018-008-8095-1

33. 33.

    Junger WG Immune cell regulation by autocrine purinergic signalling. Nature reviews. Immunology 11, 201–212 (2011 ).

    Not in our library10.1038/nri2938

34. 34.

    Chen Y ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors. Science 314, 1792–1795 (2006 ).

    Not in our library10.1126/science.1132559

35. 35.

    Lecut C P2X1 Ion Channels Promote Neutrophil Chemotaxis through Rho Kinase Activation. The Journal of Immunology 183, 2801–2809 (2009 ).

    Not in our library10.4049/jimmunol.0804007

36. 36.

    Hind LE, Vincent WJ & Huttenlocher A Leading from the Back: The Role of the Uropod in Neutrophil Polarization and Migration. Developmental cell 38, 161–169 (2016 ).

    Not in our library10.1016/j.devcel.2016.06.031

37. 37.

    Yang HW, Collins SR & Meyer T Locally excitable Cdc42 signals steer cells during chemotaxis. Nat Cell Biol 18, 191–201 (2016 ).

    Not in our library10.1038/ncb3292

38. 38.

    Condamine T Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci Immunol 1 (2016 ).

    Not in our library10.1126/sciimmunol.aaf8943

39. 39.

    Condamine T ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest 124, 2626–2639 (2014 ).

    Not in our library10.1172/jci74056

40. 40.

    Tybulewicz VL & Henderson RB Rho family GTPases and their regulators in lymphocytes. Nat Rev Immunol 9, 630–644 (2009 ).

    Not in our library10.1038/nri2606

Cited by papers we hold 14

• Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment · 2024
  No notice
• Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy · 2024
  No notice
• Pre-metastatic niche: formation, characteristics and therapeutic implication · 2024
  No notice
• Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives · 2024
  No notice
• Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy · 2022
  No notice
• Neutrophil phenotypes and functions in cancer: A consensus statement · 2022
  No notice
• Nicotine promotes breast cancer metastasis by stimulating N2 neutrophils and generating pre-metastatic niche in lung · 2021
  Retracted
• Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade · 2021
  No notice
• Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors · 2021
  No notice
• Hybrid Fc‐fused interleukin‐7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy · 2020
  Not checked
• Neutrophils: Orchestrators of the Malignant Phenotype · 2020
  Not checked
• The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses · 2020
  No notice
• Cytotoxic CD8+ T cells in cancer and cancer immunotherapy · 2020
  No notice
• Metabolic Insight of Neutrophils in Health and Disease · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.